Search

A once-daily combination treatment for those with uncontrolled Type 2 diabetes amplifies the treatment’s effects – lowering both weight and the number of hypoglycemic events, and improving quality of life and glucose control ¬– and makes participants more likely to adhere to their medications.

The molecular changes that lead to Fuchs’ endothelial corneal dystrophy (FECD) occur decades before the disease causes blurry vision and other noticeable symptoms in patients.

Shelter-in-place orders to reduce the spread of COVID-19 put unusual strains on people with obesity

The Anne Burnett Marion School of Medicine at Texas Christian University and UT Southwestern Medical Center have joined forces to address some of the highest maternal morbidity rates in the country by forming the North Texas Maternal Health Accelerator (MHA).

Ushering in a new era in cancer care in Fort Worth, UT Southwestern Medical Center broke ground today on a $177 million Radiation Oncology campus that will provide the most advanced therapies for patients of the nation’s 12th largest city.

Researchers at UT Southwestern Medical Center have discovered that a diet free of the amino acid tryptophan can effectively halt the growth of liver cancer in mice. Their findings, published in Nature Communications, offer new insights for dietary-based cancer treatments and highlight the critical

UT Southwestern Medical Center and Children’s Health announced a $25 million gift from the Harry W. Bass, Jr. Foundation, directed through Southwestern Medical Foundation, in support of their $5 billion transformative joint pediatric campus under construction in Dallas’ Southwestern Medical District

UT Southwestern Medical Center and Children’s HealthSM today announced that Goldman Sachs has committed philanthropic support to the new $5 billion joint pediatric campus under construction in Dallas’ Southwestern Medical District, across from UTSW’s William P. Clements Jr. University Hospital.

Studies highlight how collaborative research can improve the diagnosis and treatment of childhood blood disorders such as aplastic anemia and MDS

The COVID-19 pandemic has led to new rules and expectations for clinical trials.